Right. Okay, yes. Well -- so for a while, we've been looking at the life science market, which is a market where a substantial number of barcode readers are being sold into equipment that is used to analyze a test tube with your blood in it or other bodily fluids in the life science market. So we've seen that market as interesting, and we launched our first product into that market a couple of years ago and kind of liken it in some way to logistics where we launched a product a couple of years ago, the DataMan 500, which started to get us into that market. And we learned a lot. And our second kind of foray into that market, second push, is really producing substantial results. So in a way, it's analogous. Like we launched a product into that market, we learned the life science market, and we learned about it, the first image engine. And now we've launched the second family of image engines, which are -- you'll see when you come much smaller, much more powerful, lower price point. And we're now having some significant success in that marketplace with the new product. What is the product? It's a tiny but very powerful image engine, with a lot of powerful vision tools on it, not only ID but many different capabilities. And I think an important thing to understand about that life science market though, Jim, is it's a market that has a very long sales cycle. So big producers of life science equipment are developing products over about a 3-year period before they launch them, and a substantial part of it is getting government approval for the product. So we're now seeing some design wins in that marketplace, which will feed through, we believe, into substantial opportunities in revenue in coming years. But still, the near-term opportunities, you won't see in revenue for some time.
James Ricchiuti - Needham & Company, LLC, Research Division: And so when you talk about opportunities in kiosks and things like that, that's further out?